Ignite Creation Date:
2025-12-25 @ 2:21 AM
Ignite Modification Date:
2026-03-22 @ 3:17 PM
Study NCT ID:
NCT00703534
Status:
COMPLETED
Last Update Posted:
2011-06-20
First Post:
2008-06-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D9120C00027
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Debra Silberg, MD, Director of Clinical Research
Old Organization:
AstraZeneca Pharmaceuticals